546 related articles for article (PubMed ID: 26763280)
1. Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction: Risk Stratification Using Cardiovascular Magnetic Resonance.
Murtagh G; Laffin LJ; Beshai JF; Maffessanti F; Bonham CA; Patel AV; Yu Z; Addetia K; Mor-Avi V; Moss JD; Hogarth DK; Sweiss NJ; Lang RM; Patel AR
Circ Cardiovasc Imaging; 2016 Jan; 9(1):e003738. PubMed ID: 26763280
[TBL] [Abstract][Full Text] [Related]
2. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias.
Crawford T; Mueller G; Sarsam S; Prasitdumrong H; Chaiyen N; Gu X; Schuller J; Kron J; Nour KA; Cheng A; Ji SY; Feinstein S; Gupta S; Ilg K; Sinno M; Abu-Hashish S; Al-Mallah M; Sauer WH; Ellenbogen K; Morady F; Bogun F
Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1109-15. PubMed ID: 25266311
[TBL] [Abstract][Full Text] [Related]
4. Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure.
Lin LY; Su MY; Chen JJ; Lai LP; Hwang JJ; Tseng CD; Chen YS; Yu HY; Tseng WY; Lin JL
JACC Cardiovasc Imaging; 2013 Nov; 6(11):1152-9. PubMed ID: 24229767
[TBL] [Abstract][Full Text] [Related]
5. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.
Perazzolo Marra M; De Lazzari M; Zorzi A; Migliore F; Zilio F; Calore C; Vettor G; Tona F; Tarantini G; Cacciavillani L; Corbetti F; Giorgi B; Miotto D; Thiene G; Basso C; Iliceto S; Corrado D
Heart Rhythm; 2014 May; 11(5):856-63. PubMed ID: 24440822
[TBL] [Abstract][Full Text] [Related]
6. Right ventricular involvement is an important prognostic factor and risk stratification tool in suspected cardiac sarcoidosis: analysis by cardiac magnetic resonance imaging.
Kagioka Y; Yasuda M; Okune M; Kakehi K; Kawamura T; Kobuke K; Miyazaki S; Iwanaga Y
Clin Res Cardiol; 2020 Aug; 109(8):988-998. PubMed ID: 31872264
[TBL] [Abstract][Full Text] [Related]
7. Right Ventricular Abnormalities on Cardiovascular Magnetic Resonance Imaging in Patients With Sarcoidosis.
Velangi PS; Chen KA; Kazmirczak F; Okasha O; von Wald L; Roukoz H; Farzaneh-Far A; Markowitz J; Nijjar PS; Bhargava M; Perlman D; Akçakaya M; Shenoy C
JACC Cardiovasc Imaging; 2020 Jun; 13(6):1395-1405. PubMed ID: 31954639
[TBL] [Abstract][Full Text] [Related]
8. Presence of Late Gadolinium Enhancement by Cardiac Magnetic Resonance Among Patients With Suspected Cardiac Sarcoidosis Is Associated With Adverse Cardiovascular Prognosis: A Systematic Review and Meta-Analysis.
Hulten E; Agarwal V; Cahill M; Cole G; Vita T; Parrish S; Bittencourt MS; Murthy VL; Kwong R; Di Carli MF; Blankstein R
Circ Cardiovasc Imaging; 2016 Sep; 9(9):e005001. PubMed ID: 27621357
[TBL] [Abstract][Full Text] [Related]
9. Myocardial Damage Detected by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Uncommon in Peripartum Cardiomyopathy.
Schelbert EB; Elkayam U; Cooper LT; Givertz MM; Alexis JD; Briller J; Felker GM; Chaparro S; Kealey A; Pisarcik J; Fett JD; McNamara DM;
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28373243
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis.
Flamée L; Symons R; Degtiarova G; Dresselaers T; Gheysens O; Wuyts W; Van Cleemput J; Bogaert J
Eur Radiol; 2020 Jul; 30(7):3702-3710. PubMed ID: 32166494
[TBL] [Abstract][Full Text] [Related]
11. Late gadolinium enhancement in cardiac sarcoidosis: characteristic magnetic resonance findings and relationship with left ventricular function.
Watanabe E; Kimura F; Nakajima T; Hiroe M; Kasai Y; Nagata M; Kawana M; Hagiwara N
J Thorac Imaging; 2013 Jan; 28(1):60-6. PubMed ID: 23249970
[TBL] [Abstract][Full Text] [Related]
12. Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy.
Piers SR; Everaerts K; van der Geest RJ; Hazebroek MR; Siebelink HM; Pison LA; Schalij MJ; Bekkers SC; Heymans S; Zeppenfeld K
Heart Rhythm; 2015 Oct; 12(10):2106-14. PubMed ID: 26004942
[TBL] [Abstract][Full Text] [Related]
13. Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis.
Ise T; Hasegawa T; Morita Y; Yamada N; Funada A; Takahama H; Amaki M; Kanzaki H; Okamura H; Kamakura S; Shimizu W; Anzai T; Kitakaze M
Heart; 2014 Aug; 100(15):1165-72. PubMed ID: 24829369
[TBL] [Abstract][Full Text] [Related]
14. Right Ventricular Ejection Fraction Is Incremental to Left Ventricular Ejection Fraction for the Prediction of Future Arrhythmic Events in Patients With Systolic Dysfunction.
Mikami Y; Jolly U; Heydari B; Peng M; Almehmadi F; Zahrani M; Bokhari M; Stirrat J; Lydell CP; Howarth AG; Yee R; White JA
Circ Arrhythm Electrophysiol; 2017 Jan; 10(1):. PubMed ID: 28087564
[TBL] [Abstract][Full Text] [Related]
15. Electrophysiologic testing for diagnostic evaluation and risk stratification in patients with suspected cardiac sarcoidosis with preserved left and right ventricular systolic function.
Zipse MM; Tzou WS; Schuller JL; Aleong RG; Varosy PD; Tompkins C; Borne RT; Tumolo AZ; Sandhu A; Kim D; Freeman AM; Weinberger HD; Maier LA; Sung RK; Nguyen DT; Sauer WH
J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1939-1948. PubMed ID: 31257683
[TBL] [Abstract][Full Text] [Related]
16. Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study.
Patel AR; Klein MR; Chandra S; Spencer KT; Decara JM; Lang RM; Burke MC; Garrity ER; Hogarth DK; Archer SL; Sweiss NJ; Beshai JF
Eur J Heart Fail; 2011 Nov; 13(11):1231-7. PubMed ID: 21810833
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Cardiovascular Magnetic Resonance Assessment in Patients With Sarcoidosis and Preserved Left Ventricular Ejection Fraction.
Greulich S; Kitterer D; Latus J; Aguor E; Steubing H; Kaesemann P; Patrascu A; Greiser A; Groeninger S; Mayr A; Braun N; Alscher MD; Sechtem U; Mahrholdt H
Circ Cardiovasc Imaging; 2016 Nov; 9(11):. PubMed ID: 27903537
[TBL] [Abstract][Full Text] [Related]
18. Prognosis and risk stratification in cardiac sarcoidosis patients with preserved left ventricular ejection fraction.
Chiba T; Nakano M; Hasebe Y; Kimura Y; Fukasawa K; Miki K; Morosawa S; Takanami K; Ota H; Fukuda K; Shimokawa H
J Cardiol; 2020 Jan; 75(1):34-41. PubMed ID: 31277963
[TBL] [Abstract][Full Text] [Related]
19. Prediction of ventricular arrhythmias using cardiovascular magnetic resonance.
Mavrogeni S; Petrou E; Kolovou G; Theodorakis G; Iliodromitis E
Eur Heart J Cardiovasc Imaging; 2013 Jun; 14(6):518-25. PubMed ID: 23324829
[TBL] [Abstract][Full Text] [Related]
20. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study.
Masci PG; Schuurman R; Andrea B; Ripoli A; Coceani M; Chiappino S; Todiere G; Srebot V; Passino C; Aquaro GD; Emdin M; Lombardi M
Circ Cardiovasc Imaging; 2013 Sep; 6(5):790-9. PubMed ID: 23934992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
